A Wnt/Shh signaling loop controls intervertebral disc growth and differentiation
A Wnt/Shh signaling loop controls intervertebral disc growth and differentiation
批准号:
8759103
负责人:
Chitra L Dahia
金额:
$38.72万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-07-01 至 2019-04-30
关键词:
AffectAgeAgingAgonistBiologicalBiological AssayBiological Response Modifier TherapyBirthBlood CirculationCell Differentiation processCell NucleusCell ProliferationCellsDataDevelopmentDifferentiation AntigensDifferentiation and GrowthDown-RegulationEpiphysial cartilageFeedbackFibrosisFutureGaitGene TargetingGoalsGrowthHistologyIn VitroIndiumInjuryIntervertebral disc structureJointsKnowledgeLeadLigandsLiquid substanceLow Back PainMagnetic Resonance ImagingMedicalModelingMolecularMovementMusMuscleNatureNeurologicOperative Surgical ProceduresPathway interactionsProteoglycanQuality of lifeRoleSHH geneSignal PathwaySignal TransductionSiteSymptomsTestingTimeTreatment CostUp-Regulationage relatedbasedisc regenerationfetal bovine serumin vivoinhibitor/antagonistinsightintervertebral disk degenerationmolecular markernovelnucleus pulposuspalliativepostnatalprematurepublic health relevancereceptorresearch studyspine bone structurevertebra body
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This project aims to identify the molecular mechanisms of postnatal growth and differentiation of the intervertebral disc (IVD), and how these mechanisms are down-regulated, leading to age-related changes in the IVD. Each IVD consists of a central semi-liquid nucleus pulposus (NP), surrounded by a multi-layered annulus fibrosus (AF), and connected to the bodies of the adjacent vertebral bodies by cartilagenous end plates (EP). Together, these components form a strong joint that resists both tension and compression forces between vertebrae. Degenerative disc disease (DDD) is a major cause of lower back pain, and other neurological symptoms leading to a decreased quality of life. DDD is extremely common, affecting as many as one in seven people. The treatment costs are high, and often include surgical intervention. However, treatment is essentially palliative, since it treats the effects of disc degeneration rather than the causes. The long-term goal of this project is to identify potential biological approaches to therapy, using the same pathways by which the IVD normally grows and differentiates. We have developed the mouse lumbar IVD as a model, and preliminary data shows that it can be used to identify the signaling pathways in the IVD that control postnatal growth and differentiation. We have found that during postnatal growth, the NP acts as a signaling center that controls both growth and differentiation. NP cells express SHH, and blockade of Shh signaling both in vitro and in vivo shows that it is essential for cell proliferation and differentiation of the IVD. NP cells also express several Wnt ligands, which are required to maintain Shh signaling in the IVD. Both these signaling pathways, and the downstream targets of Shh signaling, are down-regulated by the end of the growth period. However, Shh signaling, and the expression of differentiation markers, can be re-activated after the growth period by signals present in fetal bovine serum, or by Wnt agonists, showing that down-regulation of growth and differentiation is not irreversible, and offers potential future targets for therapy. Aim 1 of the project tests the hypothesis that the duration of the postnatal growth period is determined by active Wnt signaling. Aim 2 tests the hypothesis that a feedback loop between Wnt and Shh signaling is established by Wnt inhibitors expressed downstream of Shh signaling. Aim 3 tests the hypothesis that circulating signals control the synchronous growth of all the IVDs by acting on Wnt/Shh signaling loop in the NP. The data from this project will provide the necessary information to explore further the nature of aging of the IVD, the basis of possible biological therapies for disc injury or degeneration, and novel scientific insights into te way growth and differentiation of the IVDs are controlled during postnatal growth.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Admin Supplement: Role of Shh/Brachyury axis in the maintenance of the postnatal intervertebral disc
-
批准号:10879520
-
项目类别:
-
资助金额:$26.85万
-
财政年份:2023
-
负责人:Chitra L Dahia
-
依托单位:
Role of Developmental Signaling Pathways in Maintenance of Spinal Discs
-
批准号:10305941
-
项目类别:
-
资助金额:$68.73万
-
财政年份:2021
-
负责人:Chitra L Dahia
-
依托单位:
Role of Developmental Signaling Pathways in Maintenance of Spinal Discs
-
批准号:10609916
-
项目类别:
-
资助金额:$63.0万
-
财政年份:2021
-
负责人:Chitra L Dahia
-
依托单位:
Role of Developmental Signaling Pathways in Maintenance of Spinal Discs
-
批准号:10469481
-
项目类别:
-
资助金额:$70.89万
-
财政年份:2021
-
负责人:Chitra L Dahia
-
依托单位:
Role of Shh/Brachyury axis in the maintenance of the postnatal intervertebral disc
-
批准号:10596619
-
项目类别:
-
资助金额:$55.17万
-
财政年份:2021
-
负责人:Chitra L Dahia
-
依托单位:
Role of Shh/Brachyury axis in the maintenance of the postnatal intervertebral disc
-
批准号:10433845
-
项目类别:
-
资助金额:$55.3万
-
财政年份:2021
-
负责人:Chitra L Dahia
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: